These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8952671)

  • 21. Mycophenolate mofetil in renal transplantation: 3-year results from the placebo-controlled trial. European Mycophenolate Mofetil Cooperative Study Group.
    Transplantation; 1999 Aug; 68(3):391-6. PubMed ID: 10459543
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Show me the money--immunosuppression in kidney transplantation.
    Burke GW; Ciancio G
    Lancet; 2004 Aug 7-13; 364(9433):481-3. PubMed ID: 15302174
    [No Abstract]   [Full Text] [Related]  

  • 23. Humoral immune response after kidney transplantation is enhanced by acute rejection and urological obstruction and is down-regulated by mycophenolate mofetil treatment.
    Oliveira JG; Monteiro MS; Teixeira JF; Osório E; Norton SM; Alves H; Pestana M
    Transpl Int; 2005 Nov; 18(11):1286-91. PubMed ID: 16221160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycophenolate mofetil dose reduction in renal transplant recipients: a 5-year follow-up study.
    Khosroshahi HT; Shoja MM; Peyrovifar A; Hashemi SR; Amjadi M
    Transplant Proc; 2009 Sep; 41(7):2797-9. PubMed ID: 19765438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycophenolate mofetil for maintenance therapy in kidney transplantation.
    Gonwa TA
    Clin Transplant; 1996 Feb; 10(1 Pt 2):128-30. PubMed ID: 8680049
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluation of everolimus versus mycophenolate mofetil in combination with cyclosporine and prednisolone in de novo renal transplant recipients.
    Holmes M; Chilcott J; Walters S; Whitby S; Akehurst R
    Transpl Int; 2004 May; 17(4):182-7. PubMed ID: 15107971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prophylactic effect of mycophenolate mofetil on early outcomes of living donor kidney transplantation.
    Samadzadeh B; Alemi M; Heidarnejadiyan J; Torkamanasadi F
    Iran J Kidney Dis; 2012 Jan; 6(1):63-8. PubMed ID: 22218122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Improved outcome of pediatric kidney transplantations in the Netherlands -- effect of the introduction of mycophenolate mofetil?
    Cransberg K; Marlies Cornelissen EA; Davin JC; Van Hoeck KJ; Lilien MR; Stijnen T; Nauta J
    Pediatr Transplant; 2005 Feb; 9(1):104-11. PubMed ID: 15667622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
    Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of mycophenolate mofetil versus azathioprine and mycophenolic acid pharmacokinetics on the incidence of acute rejection and infectious complications after renal transplantation.
    Satoh S; Tada H; Murakami M; Tsuchiya N; Inoue T; Togashi H; Matsuura S; Hayase Y; Suzuki T; Habuchi T
    Transplant Proc; 2005 May; 37(4):1751-3. PubMed ID: 15919454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mycophenolate mofetil in renal transplantation: results from the U.S. randomized trials.
    Danovitch GM
    Kidney Int Suppl; 1995 Dec; 52():S93-6. PubMed ID: 8587293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized, prospective trial of mycophenolate mofetil versus azathioprine for prevention of acute renal allograft rejection after simultaneous kidney-pancreas transplantation.
    Merion RM; Henry ML; Melzer JS; Sollinger HW; Sutherland DE; Taylor RJ
    Transplantation; 2000 Jul; 70(1):105-11. PubMed ID: 10919583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in the use of immunosuppressive agents by outpatients after renal transplantation at a medical center in southern Taiwan.
    Mao PC; Lee EK; Tseng PL
    Transplant Proc; 2012 Jan; 44(1):185-9. PubMed ID: 22310611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil.
    Chandrakantan A; Ratanapanichkich P; Said M; Barker CV; Julian BA
    Nephrol Dial Transplant; 2005 Jun; 20(6):1214-21. PubMed ID: 15797890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcineurin inhibitor-free immunosuppression based on antithymocyte globulin and mycophenolate mofetil in cadaveric kidney transplantation: results after 5 years.
    Grinyó JM; Gil-Vernet S; Cruzado JM; Caldés A; Riera L; Serón D; Rama I; Torras J
    Transpl Int; 2003 Nov; 16(11):820-7. PubMed ID: 12879230
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate mofetil--a new immunosuppressant for organ transplantation.
    Med Lett Drugs Ther; 1995 Sep; 37(958):84-6. PubMed ID: 7674993
    [No Abstract]   [Full Text] [Related]  

  • 37. Mycophenolate mofetil versus azathioprine for prevention of chronic allograft dysfunction in renal transplantation: the MYSS follow-up randomized, controlled clinical trial.
    Remuzzi G; Cravedi P; Costantini M; Lesti M; Ganeva M; Gherardi G; Ene-Iordache B; Gotti E; Donati D; Salvadori M; Sandrini S; Segoloni G; Federico S; Rigotti P; Sparacino V; Ruggenenti P
    J Am Soc Nephrol; 2007 Jun; 18(6):1973-85. PubMed ID: 17460145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of generics in kidney transplant: mycophenolate mofetil 500 versus mycophenolate: 2-year results.
    Abdallah TB; Ounissi M; Cherif M; Helal I; Karoui C; Mhibik S; Bacha MM; Abderrahim E; Kheder A
    Exp Clin Transplant; 2010 Dec; 8(4):292-6. PubMed ID: 21143094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steroid avoidance reduce the cost of morbidities after live-donor renal allotransplants: a prospective, randomized, controlled study.
    Gheith OA; Nematalla AH; Bakr MA; Refaie A; Shokeir AA; Ghoneim MA
    Exp Clin Transplant; 2011 Apr; 9(2):121-7. PubMed ID: 21453230
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preemptive Renal Transplantation-The Best Treatment Option for Terminal Chronic Renal Failure.
    Arze Aimaretti L; Arze S
    Transplant Proc; 2016 Mar; 48(2):609-11. PubMed ID: 27110013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.